| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cibus, Inc. (CBUS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. CBUS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 894.3K | $1.22M | - | |
| CEO | 686.8K | $934.1K | - | |
| VP | 422.9K | $575.1K | - | |
| Other | 167.9K | $228.3K | - | |
| CFO | 154.3K | $209.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2018 | Bowers Glenn R | Vice President Of Breeding | Sell | 423 | $19.49 | $8,244.27 | -4.7% | |
| Jun 15, 2018 | Choulika Andre | Director | Sell | 2,352 | $19.49 | $45,840.48 | -1.5% | |
| May 21, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,666 | $16.63 | $77,589.05 | -4.4% | |
| May 8, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,083 | $15.58 | $63,595.58 | -3.9% | |
| Apr 20, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,666 | $16.87 | $78,700.96 | -4.4% | |
| Apr 9, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,083 | $14.38 | $58,733.55 | -3.9% | |
| Mar 20, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,666 | $17.91 | $83,560.59 | -100% | |
| Mar 12, 2018 | Godard Alain | Director | Sale+OE | 30,000 | $19.00 | $570,000.00 | -20.3% | |
| Feb 28, 2018 | Arbadji Michel | Director Of Business Developme | Sale+OE | 3,500 | $18.63 | $65,219.70 | -10.6% | |
| Feb 26, 2018 | Godard Alain | Director | Sale+OE | 10,000 | $19.03 | $190,262.00 | -20.3% |